Francisella novicida

Last updated

Francisella novicida
Scientific classification Red Pencil Icon.png
Domain: Bacteria
Phylum: Pseudomonadota
Class: Gammaproteobacteria
Order: Thiotrichales
Family: Francisellaceae
Genus: Francisella
Species:
F. novicida
Binomial name
Francisella novicida
(Larson et al. 1955) Olsufiev et al. 1959 (Approved Lists 1980)

Francisella novicida is a bacterium of the Francisellaceae family, which consist of Gram-negative pathogenic bacteria. These bacteria vary from small cocci to rod-shaped, and are most known for their intracellular parasitic capabilities. In this family, six species have been identified; however, the species F. novicida is under intense scrutiny. Though some believe it should be classified with its own species designation, others argue it should be reclassified as a subspecies under F. tularensis. If it were to be classified as a subspecies, F. novicida would join the other known subspecies including F. t. tularensis (type A) and F. t. holarctica (type B). Biochemical assays for identifying F. tularensis subtypes and strains are not ideal because the results are often non-definitive and subject to variation, therefore these assays should only be considered as supplementary tests for identification of Francisella species and subspecies. [1] [2] Several strains of F. novicida or F. novicida-like bacteria have been described, and these strains may be resolved by PCR-based methods. [3]

Though F. novicida is considered a rare pathogen, its close relative F. tularensis is well known for causing tularemia. Unlike F. tularensis, there have been no documented cases of F. novicida or F. novicida-like strain transmission to humans through arthropod bites. The route of infection for the majority of human F. novicida or F. novicida-'like' cases is unknown, although infected water or ice have been implicated. Some of the main symptoms associated with this infection include pneumonia, muscle pain, and fever, among many others. When reported, cases of F. novicida or F. novicida-like infections are most commonly seen in immunocompromised people. Though F. novicida is rarely associated with human illness despite the close genetic relationship to F. tularensis, cases have been reported in humans in the United States. For example, one case of F. novicida involved a woman in Arizona in 2009. [1] Additionally, in 2011, three confirmed cases of F. novicida were found in a residential facility in Louisiana. In the later case, ice was the mode of transmission; however, how the ice was originally contaminated with the F. novicida is still unknown. [4]

Classification arguments

The transfer of F. novicida to a Francisella tularensis subsp. novicida has been recommended, and many microbiologists already use this name. Results of DNA-DNA hybridization and genome sequencing experiments indicate F. novicida is genetically close to F. tularensis. Also, the phenotypic differences observed are in agreement with the subspecies concept. From some scientists’ points of view, it is not consistent to have a species F. tularensis with three subspecies supported by the DNA-DNA hybridization data, but distinct by phenotypic traits and thus considered a separate species. The DNA-DNA relatedness was greater than 85%. Human or animal infections with F. t. novicida are very rare and few publications describe it, in part because it is infrequently isolated. This indicates most laboratories are not able to distinguish the two subspecies based on phenotype or metabolic requirements. [5] For medically important organisms such as Francisella, clear guidelines exist for differentiation of subspecies. According to EU guideline 2000/54/EC, which has been adopted in 27 European countries, F. t. tularensis [F. tularensis (type A)] is classified as a BSL 3 pathogen, while F. t. holarctica [F. tularensis (type B)] is classified as a BSL 2 pathogen. Eleven metabolic reactions have been found to differ in F. novicida and F. tularensis. Many scientists argue this is not enough among the 98 traits to contradict F. novicida as a subspecies. It is common for bacterial species to be composed of individuals that are not identical in phenotypic traits. For example, the size of the Escherichia coli genome ranges from 4.6 to 5.7 Mb. This means the strains of a single species may differ in 20-25% of their genome without affecting their taxonomic status. Therefore, many believe more metabolic diversity is needed to distinguish the two as separate species. While all of this supports F. novicida to be classified as a subspecies, many still believe enough evidence exists to create a separate species.

When F. novicida and F. tularensis are grown, they appear to be morphologically very similar. They are both Gram-negative bacilli. Many tests have been done to try to distinguish if F. novicida and F. tularensis should be considered separate species. One of these tests involved growth on cysteine-glucose-blood agar (CGBA). F. tularensis took 2 to 7 days to appear on the CGBA, while F. novicida took only 24 hours to appear. [6] F. novicida grows much more rapidly on CGBA than F. tularensis. Another difference between the two is the virulence of F. novicida was lower. F. tularensis was highly virulent in the mice and cavies (guinea pigs) used in studies. It only took one to 10 cells of F. tularensis to kill the animal of either species, although F. novicida took 10 to 100 cells in cavies and up to a 1,000 cells in mice. The immunological differences, though, are the strongest evidence used to support the idea that F. novicida and F. tularensis are separate species. Nonliving vaccines provided no protection against the heterologous organism. However, these nonliving vaccines did provide protection against the homologous organism. The living vaccines provided protection and cross-protection. as well. No protection was demonstrated against F. tularensis when using an F. novicida vaccine in any experiment. [6] Therefore, a fundamental difference appears to exist in the antigenic composition of the two organisms, which was also demonstrated by cross-absorption in passive cutaneous anaphylaxis test (PCAs). The ability of the given antigen to remove all reactivity from its homologous antiserum while leaving the heterologous antiserum intact indicates the lack of antigen identity. To many scientists, this is enough proof to consider F. novicida and F. tularensis as separate species. Much debate still occurs over how to classify the two organisms, and it is important for scientists to establish a species concept for this organism due to its medical relevance.[ citation needed ]

Related Research Articles

<i>Yersinia pestis</i> Species of bacteria, cause of plague

Yersinia pestis is a gram-negative, non-motile, coccobacillus bacterium without spores that is related to both Yersinia pseudotuberculosis and Yersinia enterocolitica. It is a facultative anaerobic organism that can infect humans via the Oriental rat flea. It causes the disease plague, which caused the first plague pandemic and the Black Death, the deadliest pandemic in recorded history. Plague takes three main forms: pneumonic, septicemic, and bubonic.

<i>Escherichia coli</i> Enteric, rod shaped, gram-negative bacterium

Escherichia coli, also known as E. coli, is a Gram-negative, facultative anaerobic, rod-shaped, coliform bacterium of the genus Escherichia that is commonly found in the lower intestine of warm-blooded organisms. Most E. coli strains are harmless, but some serotypes (EPEC, ETEC etc.) can cause serious food poisoning in their hosts, and are occasionally responsible for food contamination incidents that prompt product recalls. The harmless strains are part of the normal microbiota of the gut, and can benefit their hosts by producing vitamin K2, and preventing colonisation of the intestine with pathogenic bacteria, having a mutualistic relationship. E. coli is expelled into the environment within fecal matter. The bacterium grows massively in fresh fecal matter under aerobic conditions for three days, but its numbers decline slowly afterwards.

DNA vaccine Vaccine containing DNA

A DNA vaccine is a type of vaccine that transfects a specific antigen-coding DNA sequence into the cells of an organism as a mechanism to induce an immune response.

<i>Treponema pallidum</i> Species of bacterium

Treponema pallidum is a spirochaete bacterium with various subspecies that cause the diseases syphilis, bejel, and yaws. It is chiefly transmitted amongst humans, but it can also cause a condition found in cattle, bovine digital dermatitis. It is a helically coiled microorganism usually 6–15 μm long and 0.1–0.2 μm wide. T. pallidum's lack of either a tricarboxylic acid cycle or oxidative phosphorylation results in minimal metabolic activity. The treponemes have a cytoplasmic and an outer membrane. Using light microscopy, treponemes are visible only by using dark field illumination. Treponema pallidum consists of three subspecies, T. p. pallidum, T. p. endemicum, and T. p. pertenue, each of which has a distinct associated disease.

<i>Neisseria</i> Genus of bacteria

Neisseria is a large genus of bacteria that colonize the mucosal surfaces of many animals. Of the 11 species that colonize humans, only two are pathogens, N. meningitidis and N. gonorrhoeae. Most gonococcal infections are asymptomatic and self-resolving, and epidemic strains of the meningococcus may be carried in >95% of a population where systemic disease occurs at <1% prevalence.

Tularemia Infectious disease caused by the bacterium Francisella tularensis

Tularemia, also known as rabbit fever, is an infectious disease caused by the bacterium Francisella tularensis. Symptoms may include fever, skin ulcers, and enlarged lymph nodes. Occasionally, a form that results in pneumonia or a throat infection may occur.

In biology, immunity is the capability of multicellular organisms to resist harmful microorganisms. Immunity involves both specific and nonspecific components. The nonspecific components act as barriers or eliminators of a wide range of pathogens irrespective of their antigenic make-up. Other components of the immune system adapt themselves to each new disease encountered and can generate pathogen-specific immunity.

<i>Chlamydia trachomatis</i> Species of bacterium

Chlamydia trachomatis, commonly known as chlamydia, is a bacterium that causes chlamydia, which can manifest in various ways, including: trachoma, lymphogranuloma venereum, nongonococcal urethritis, cervicitis, salpingitis, pelvic inflammatory disease. C. trachomatis is the most common infectious cause of blindness and the most common sexually transmitted bacterium.

Mycoplasma pneumoniae is a very small bacterium in the class Mollicutes. It is a human pathogen that causes the disease mycoplasma pneumonia, a form of atypical bacterial pneumonia related to cold agglutinin disease. M. pneumoniae is characterized by the absence of a peptidoglycan cell wall and resulting resistance to many antibacterial agents. The persistence of M. pneumoniae infections even after treatment is associated with its ability to mimic host cell surface composition.

<i>Acinetobacter</i> Genus of bacteria

Acinetobacter is a genus of gram-negative bacteria belonging to the wider class of Gammaproteobacteria. Acinetobacter species are oxidase-negative, exhibit twitching motility, and occur in pairs under magnification.

<i>Haemophilus influenzae</i> Species of bacterium

Haemophilus influenzae is a Gram-negative, coccobacillary, facultatively anaerobic capnophilic pathogenic bacterium of the family Pasteurellaceae. H. influenzae was first described in 1892 by Richard Pfeiffer during an influenza pandemic. He incorrectly described Haemophilus influenzae as the causative microbe, which retains "influenza" in its name.

<i>Francisella</i> Genus of bacteria

Francisella is a genus of pathogenic, Gram-negative bacteria. They are small coccobacillary or rod-shaped, nonmotile organisms, which are also facultative intracellular parasites of macrophages. Strict aerobes, Francisella colonies bear a morphological resemblance to those of the genus Brucella.

<i>Francisella tularensis</i> Species of bacterium

Francisella tularensis is a pathogenic species of Gram-negative coccobacillus, an aerobic bacterium. It is nonspore-forming, nonmotile, and the causative agent of tularemia, the pneumonic form of which is often lethal without treatment. It is a fastidious, facultative intracellular bacterium, which requires cysteine for growth. Due to its low infectious dose, ease of spread by aerosol, and high virulence, F. tularensis is classified as a Tier 1 Select Agent by the U.S. government, along with other potential agents of bioterrorism such as Yersinia pestis, Bacillus anthracis, and Ebola virus. When found in nature, Francisella tularensis can survive for several weeks at low temperatures in animal carcasses, soil, and water. In the laboratory, F. tularensis appears as small rods, and is grown best at 35–37 °C.

Rhinosporidium seeberi is a eukaryotic pathogen responsible for rhinosporidiosis, a disease which affects humans, horses, dogs, and to a lesser extent cattle, cats, foxes, and birds. It is most commonly found in tropical areas, especially India and Sri Lanka.

Influenza Infectious disease, "the flu"

Influenza, commonly known as "the flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin from one to four days after exposure to the virus and last for about 2–8 days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia, which can be caused by the virus or by a subsequent bacterial infection. Other complications of infection include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

Microbial toxins are toxins produced by micro-organisms, including bacteria, fungi, protozoa, dinoflagellates, and viruses. Many microbial toxins promote infection and disease by directly damaging host tissues and by disabling the immune system. Endotoxins most commonly refer to the lipopolysaccharide (LPS) or lipooligosaccharide (LOS) that are in the outer plasma membrane of Gram-negative bacteria. The botulinum toxin, which is primarily produced by Clostridium botulinum and less frequently by other Clostridium species, is the most toxic substance known in the world. However, microbial toxins also have important uses in medical science and research. Currently, new methods of detecting bacterial toxins are being developed to better isolate and understand these toxin. Potential applications of toxin research include combating microbial virulence, the development of novel anticancer drugs and other medicines, and the use of toxins as tools in neurobiology and cellular biology.

A neutralizing antibody (NAb) is an antibody that defends a cell from a pathogen or infectious particle by neutralizing any effect it has biologically. Neutralization renders the particle no longer infectious or pathogenic. Neutralizing antibodies are part of the humoral response of the adaptive immune system against viruses, intracellular bacteria and microbial toxin. By binding specifically to surface structures (antigen) on an infectious particle, neutralizing antibodies prevent the particle from interacting with its host cells it might infect and destroy. Immunity due to neutralizing antibodies is also known as sterilizing immunity, as the immune system eliminates the infectious particle before any infection takes place.

Pathogenic <i>Escherichia coli</i> Strains of E. coli that can cause disease

Escherichia coli is a gram-negative, rod-shaped bacterium that is commonly found in the lower intestine of warm-blooded organisms (endotherms). Most E. coli strains are harmless, but pathogenic varieties cause serious food poisoning, septic shock, meningitis, or urinary tract infections in humans. Unlike normal flora E. coli, the pathogenic varieties produce toxins and other virulence factors that enable them to reside in parts of the body normally not inhabited by E. coli, and to damage host cells. These pathogenic traits are encoded by virulence genes carried only by the pathogens.

This glossary of virology is a list of definitions of terms and concepts used in virology, the study of viruses, particularly in the description of viruses and their actions. Related fields include microbiology, molecular biology, and genetics.

Several small RNAs have been identified in Francisella tularensis, pathogenic bacterium that causes the disease tularaemia. Very little is known about Francisella's regulatory networks that allow this bacterium to survive in many environments.

References

  1. 1 2 Birdsell, Dawn (2009). "Francisella tularensis subsp. novicida isolated from a human in Arizona". BMC Research Notes. 2: 223. doi:10.1186/1756-0500-2-223. PMC   2780447 . PMID   19895698.
  2. Whipp, Margaret J.; Davis, Jennifer M.; Lum, Gary; Boer, Jim de; Zhou, Yan; Bearden, Scott W.; Petersen, Jeannine M.; Chu, May C.; Hogg, Geoff (2003-09-01). "Characterization of a novicida-like subspecies of Francisella tularensis isolated in Australia". Journal of Medical Microbiology. 52 (9): 839–842. doi:10.1099/jmm.0.05245-0. PMID   12909664.
  3. Johansson, Anders; Ibrahim, Ashraf; Göransson, Ingela; Eriksson, Ulla; Gurycova, D.; Clarridge, Jill E.; Sjöstedt, Anders (2000-11-01). "Evaluation of PCR-Based Methods for Discrimination of Francisella Species and Subspecies and Development of a Specific PCR That Distinguishes the Two Major Subspecies of Francisella tularensis". Journal of Clinical Microbiology. 38 (11): 4180–4185. doi:10.1128/JCM.38.11.4180-4185.2000. ISSN   0095-1137. PMC   87560 . PMID   11060087.
  4. "Outbreak of Francisella novicida Infections Among Occupants at a Long-Term Residential Facility".
  5. Busse, Hans-Jürgen; Huber (August 2010). "Objections to the transfer of Francisella novicida to the subspecies rank of Francisella tularensis – response to Johansson et al". International Journal of Systematic and Evolutionary Microbiology. 60 (8): 1718–20. doi: 10.1099/00207713-60-8-1718 . PMID   20688749.
  6. 1 2 Owen, C.R.; Buker, EO; Jellison, WL; Lackman, DB; Bell, JF (March 1964). "Comparative studies of Francisella tularensis and Francisella novicida". Journal of Bacteriology. 87 (3): 676–683. doi:10.1128/jb.87.3.676-683.1964. PMC   277070 . PMID   14127585.